About one-third of depression patients do not respond to standard antidepressants. A new treatment called PACE uses ...
RED BANK, NJ / ACCESS Newswire / August 20, 2025 / Tharimmune, Inc. (THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company dedicated to developing innovative therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results